Today, the first population-based, real-world evidence (RWE) of the positive benefits infants receive when passively immunized to prevent respiratory syncytial virus (RSV) disease was published.
RWE demonstrates if immunization is effective in day-to-day practice, as opposed to "efficacy" determined in carefully controlled clinical trials.
Passive Immunization Reduced RSV Related Infant Hospitalizations by 82%
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
Initial decrease seen in proportion with inappropriate prescription, followed by subsequent increase
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
Deficits appear to be greatest for individuals with the original untyped and alpha variant infections